Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | MIF | P14174 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | PTP4A1 | Q93096 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.46 |
| ▸ | USP2 | O75604 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.44 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1127029 | 1.00 | CYP2C9 (0.59) | CYP2C9ALDH1A1TSHRMIFMAPT | |
| SCHEMBL23835988 | 1.00 | CYP2C9 (0.59) | CYP2C9ALDH1A1TSHRMIFMAPT | |
| SCHEMBL12674556 | 0.87 | CYP2C9 (0.57) | CYP2C9ALDH1A1TSHRMIFMAPT | |
| SCHEMBL23836013 | 0.86 | CYP2C9 (0.44) | CYP2C9ALDH1A1TSHRMIFMAPT | |
| SCHEMBL27511755 | 0.83 | TP53 (0.44) | CYP2C9ALDH1A1TSHRMIFMAPT | |
| SCHEMBL5554979 | 0.82 | CYP2C9 (0.40) | CYP2C9ALDH1A1TSHRMIFMAPT | |
| SCHEMBL4906704 | 0.82 | CYP2C9 (0.69) | CYP2C9ALDH1A1TSHRMIFMAPT | |
| SCHEMBL4961560 | 0.82 | CYP2C9 (0.69) | CYP2C9ALDH1A1TSHRMIFMAPT | |
| SCHEMBL2755215 | 0.82 | CYP2C9 (0.69) | CYP2C9ALDH1A1TSHRMIFMAPT | |
| SCHEMBL16159975 | 0.81 | KDM4E (0.49) | CYP2C9ALDH1A1TSHRMIFMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9752049-B2 | Optically transparent, superhydrophobic, biocompatible thin film coatings and methods for producing same | UT-BATTELLE, LLC (US) | 2017-09-05 | — | — | US | claimed |
| US-20150232690-A1 | OPTICALLY TRANSPARENT, SUPERHYDROPHOBIC, BIOCOMPATIBLE THIN FILM COATINGS AND METHODS FOR PRODUCING SAME | UT-BATTELLE, LLC (US) | 2015-08-20 | — | — | US | claimed |
| EP-1360257-B1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE R & D LTD (IE) | 2007-07-25 | — | — | EP | claimed |
| US-6977278-B1 | Cyanoacrylate compositions curable to flexible polymeric materials | LOCTITE (R&D) LTD. (IE) | 2005-12-20 | — | — | US | claimed |
| WO-2004024467-A2 | SURFACE-MOUNTING SYSTEM | LOCTITE (R & D) LIMITED (IE) | 2004-03-25 | — | — | WO | claimed |
| EP-1360257-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | Loctite (R & D) Limited (IE) | 2003-11-12 | — | — | EP | claimed |
| WO-2002053666-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE (R & D) LIMITED (IE) | 2002-07-11 | — | — | WO | claimed |
| EP-3947586-A1 | FLEXIBLE PHOTOCURABLE CYANOACRYLATE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2022-02-09 | — | — | EP | disclosed |
| US-20220033544-A1 | FLEXIBLE PHOTOCURABLE CYANOACRYLATE COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2022-02-03 | — | — | US | disclosed |
| WO-2020206405-A1 | FLEXIBLE PHOTOCURABLE CYANOACRYLATE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2020-10-08 | — | — | WO | disclosed |
| EP-2999689-B1 | CYANOACRYLATE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2017-10-04 | — | — | EP | disclosed |
| US-9752049-B2 | Optically transparent, superhydrophobic, biocompatible thin film coatings and methods for producing same | UT-BATTELLE, LLC (US) | 2017-09-05 | — | — | US | disclosed |
| CN-106518660-A | Preparation method of alpha-ketoleucine calcium dihydrate or alpha-ketophenylalanine calcium monohydrate | 浙江新和成股份有限公司 | 2017-03-22 | — | — | CN | disclosed |
| US-7189747-B2 | Method of treating noninflammatory cartilage damage | WARNER-LAMBERT COMPANY (US) | 2007-03-13 | — | — | US | disclosed |
| US-20070027212-A1 | ALPHA 2 DELTA LIGANDS FOR FIBROMYALGIA AND OTHER DISORDERS | PFIZER INC | 2007-02-01 | — | — | US | disclosed |
| US-6977278-B1 | Cyanoacrylate compositions curable to flexible polymeric materials | LOCTITE (R&D) LTD. (IE) | 2005-12-20 | — | — | US | disclosed |
| WO-2004024467-A2 | SURFACE-MOUNTING SYSTEM | LOCTITE (R & D) LIMITED (IE) | 2004-03-25 | — | — | WO | disclosed |
| EP-1360257-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | Loctite (R & D) Limited (IE) | 2003-11-12 | — | — | EP | disclosed |
| WO-2002053666-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE (R & D) LIMITED (IE) | 2002-07-11 | — | — | WO | disclosed |
| US-4261988-A | ANTICHOLESTEROL AGENTS USED IN ANIMAL HUSBANDRY | BAYER AKTIENGESELLSCHAFT (DE) | 1981-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070027212-A1 | ALPHA 2 DELTA LIGANDS FOR FIBROMYALGIA AND OTHER DISORDERS | OPRD1, HCRTR2, OPRL1 | CYP2C9 1641/4885ALDH1A1 1174/4885TSHR 218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.